Theme: Advances & Improving Treatment and Prevention of Infectious Diseases

Euro Infectious Diseases 2016

Renowned Speakers

Euro Infectious Diseases 2016

ConferenceSeries Ltd Conferences invites all the participants from all over the world to attend "3rd Euro-Global Conference on Infectious Diseases" during September 5-6, 2016 in Frankfurt, Germany which includes prompt Keynote Presentations, Oral talks, Poster presentations and Exhibitions.

Track 1: Viral Infectious Diseases

Viral Infectious Disease occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. There are many types of viruses that cause a wide variety of viral diseases. The most common type of viral disease is the common cold, which is caused by a viral infection of the upper respiratory tract (nose and throat). Viral diseases are contagious and spread from person to person when a virus enters the body and begins to multiply. Viral diseases result in a wide variety of symptoms that vary in character and severity depending on the type of viral infection and other factors, including the person’s age and overall health.

Related Conference on Viral Infectious Diseases

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 2: Bacterial Infectious Diseases

Bacteria are living things that have only one cell. Under a microscope, they look like balls, rods, or spirals. They are so small that a line of 1,000 could fit across a pencil eraser. Most bacteria won't hurt you - less than 1 percent of the different types make people sick. Many are helpful. Some bacteria help to digest food, destroy disease-causing cells, and give the body needed vitamins. Bacteria are also used in making healthy foods like yogurt and cheese. But infectious bacteria can make you ill. They reproduce quickly in your body. Many give off chemicals called toxins, which can damage tissue and make you sick. Examples of bacteria that cause infections include Streptococcus, Staphylococcus, and E. coli. Antibiotics are the usual treatment. When you take antibiotics, follow the directions carefully. Each time you take antibiotics, you increase the chances that bacteria in your body will learn to resist them causing antibiotic resistance. Later, you could get or spread an infection that those antibiotics cannot cure.

Related Conference on Bacterial Infectious Diseases

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 3: Fungal Infectious Diseases

Fungi are everywhere. There are approximately 1.5 million different species of fungi on Earth, but only about 300 of those are known to make people sick. Fungal diseases are often caused by fungi that are common in the environment. Fungi live outdoors in soil and on plants and trees as well as on many indoor surfaces and on human skin. Most fungi are not dangerous, but some types can be harmful to health. Fungal diseases can affect anyone. Learning about them can help you and your doctor recognize the symptoms of a fungal disease early and may help prevent serious complications. Fungal diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis. Some fungal diseases like fungal meningitis and bloodstream infections are less common than skin and lung infections but can be deadly.

Related Conference on Fungal Infectious Diseases

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 4: New Antiviral, Antibacterial and Antifungal Agents

Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.

Related Conference on New Antiviral, Antibacterial and Antifungal Agents

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 5: Market Analysis

Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Related Conference on Infectious Disease Global Market

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 6: Parasitic Diseases

parasitic disease is an infectious disease caused or transmitted by a parasite. Many parasites do not cause diseases. Parasitic diseases can affect practically all living organisms, including plants and mammals. The study of parasitic diseases is called parasitology. Some parasites like Toxoplasma gondii and Plasmodium spp. can cause disease directly, but other organisms can cause disease by the toxins that they produce. Although organisms such as bacteria function as parasites, the usage of the term "parasitic disease" is usually more restricted. The three main types of organisms causing these conditions are protozoa (causing protozoan infection), helminths (helminthiasis), and ectoparasites. Protozoa and helminths are usually endoparasites (usually living inside the body of the host), while ectoparasites usually live on the surface of the host. Occasionally the definition of "parasitic disease" is restricted to diseases due to endoparasites. 

Related Conference on Parasitic Diseases

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 7: Bacterial Susceptibility & Resistance

When a microorganism is isolated from a patient, the microbiology lab will often perform susceptibility testing. There is often confusion about what these results mean and how it can be used by the clinician to guide the treatment of the patient. The goal of antimicrobial susceptibility testing is to predict the in vivo success or failure of antibiotic therapy. Tests are performed in vitro, and measure the growth response of an isolated organism to a particular drug or drugs. The tests are performed under standardized conditions so that the results are reproducible. The test results should be used to guide antibiotic choice. The results of antimicrobial susceptibility testing should be combined with clinical information and experience when selecting the most appropriate antibiotic for your patient.

Related Conference on Bacterial Susceptibility & Resistance

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 8: Nosocomial Infections

Nosocomial infections are infections are acquired in hospitals and other healthcare facilities. To be classified as a Nosocomial infection, the patient must have been admitted for reasons other than the infection. He or she must also have shown no signs of active or incubating infection. Urinary tract infections are the most common type of nosocomial infection. In the United States, surgical site infections, bloodstream infections, and pneumonia are the other most common types. The location of a nosocomial infection depends on the nature of a patient's hospital procedure.

Related Conference on Nosocomial Infections

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 9: Detection and Preventing Infections in healthcare

Healthcare-associated infections are a threat to patient safety. Hospitalization for an acute illness, trauma, chronic care, or other health care conditions is a common occurrence. There were 39.2 million hospital discharges in 2005, with an average length of stay of 4.6 days. Hospitalization brings associated risks, including risk of infection. Nosocomial infections, or hospital-associated infections, are estimated to occur in 5 percent of all acute care hospitalizations, or 2 million cases per year. Hospital-associated infections have been identified as one of the most serious patient safety issues in health care. Infections that become clinically evident after 48 hours of hospitalization are considered hospital-associated. Risks factors for hospital-associated infections are generally categorized into three areas: iatrogenic, organizational, or patient-related. Iatrogenic risk factors include invasive procedures (e.g., intubation, indwelling vascular lines, urine catheterization) and antibiotic use and prophylaxis. Organizational risk factors include such things as contaminated air-conditioning systems, contaminated water systems, staffing (e.g., nurse-to-patient ratio), and physical layout of the facility (e.g., open beds close together). Examples of patient-related risk factors include severity of illness, immunosuppression, and length of stay.

Related Conference on Detection and Preventing Infections in healthcare

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 10: Public Health Practice

The Public Health Practice concentration is geared toward students who are able to enroll in courses that utilize a combination of on-line, video conference, and in person teaching modalities.  Students selecting the public health practice program should possess an academic background in a public health related field and/or experience working or volunteering within at least one public health program. Work includes subject matter in the core areas of public health: EpidemiologyBiostatistics, Environmental and occupational health, Public health policy and management, Socio-cultural and behavioral aspects of public health.

Related Conference on Public Health Practice

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 11: Vaccines

The increase in life expectancy during the 20th century is largely due to improvements in child survival; this increase is associated with reductions in infectious disease mortality, due largely to immunization. However, infectious diseases remain a major cause of illness, disability, and death. Immunization recommendations in the United States currently target 17 vaccine-preventable diseases across the lifespan. Healthy People 2020 goals for immunization and infectious diseases are rooted in evidence-based clinical and community activities and services for the prevention and treatment of infectious diseases. Objectives new to Healthy People 2020 focus on technological advancements and ensuring that States, local public health departments, and nongovernmental organizations are strong partners in the Nation’s attempt to control the spread of infectious diseases. Objectives for 2020 reflect a more mobile society and the fact that diseases do not stop at geopolitical borders. Awareness of disease and completing prevention and treatment courses remain essential components for reducing infectious disease transmission.

Related Conference on Vaccines

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International conference on Flu, October 31- November 02, 2016 USA, 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, November 24-26, 2016 Australia, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

Track 12: Respiratory Diseases

Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer. The study of respiratory disease is known as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist. UBET Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause (aetiology) of the disease.

Related Conference on Respiratory Diseases

3rd Euro-Global Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 3rd Euro-Global Emerging Infectious Diseases Conferences September 5-6, 2016 Frankfurt, Germany, 2nd International Conference on Respiratory and Pulmonary Medicine, October 17-19, 2016 USA, Annual Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 USA, 3rd International Conference on Chronic Obstructive Pulmonary Disease (COPD), July 11-12, 2016 Australia,  4th International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016 USA, 2nd International Conference on Influenza, September 12-13, 2016 Berlin, Germany, 17th Infectious Diseases Conference, March 2-5, 2016 India, 34th Annual Infectious Diseases Conference, February 5-6, 2016 USA, Status Quo of Brain Infections, 4 - 7 September 2016, Turkey,  Infection Prevention and control (IPAC), May 15 - 18, 2016 Canada, 26th European Congress of Clinical Microbiology and Infectious Diseases, April 09 – 12, 2016 Turkey, 18th International Conference on Clinical Microbiology and Infectious Diseases, May 23 - 24, 2016 UK

OMICS International Conferences invites all the participants from all over the world to attend ‘Infectious Diseases Europe 2016’ which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions. 

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represent an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles( 1 million), HIV/AIDS(1 million), Hepatitis B( 1.1million), Malaria(2.1million), Diarrhea(3.1 million), Tuberculosis (3.1 million), Respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 day event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targetted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

 

For Scientific Sessions please go through the link: http://infection.omicsgroup.com/europe/call-for-abstracts.php

For Abstract Submission please go through the link:  http://infection.omicsgroup.com/europe/abstract-submission.php

 

 

Scope and Importance of Infection Control

Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control.  Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.

Why Frankfurt (Germany)?

 

Since 2003, Germany possesses a network of medical competence and treatment centres to care for persons with highly infectious diseases (STAKOB). The clinics are distributed all over the country and the system is so organised that patients can be transported quickly and safely to one of the fa-cilities, the disease diagnosed and the necessary treatment provided. Very well-trained personnel stand ready to fulfil this task. The Federal Lander are responsible for guaranteeing a high level of appropriate training and simulation exercises at all of these facilities. Germany possesses a number of specialised airports (Hamburg, Düsseldorf, Frankfurt, and Munich) that are prepared to manage highly contagious diseases among passengers.

In 2001, the German Protection against Infection Act came into force, implementing a variety of new regulations. For the first time, obligatory infection control visits of the public health departments in surgical ambulatory practices were implemented, as well as optional infection control visits in all medical, dental and paramedical practices using invasive methods. Based on the data of the public health department of the city of Frankfurt am Main, Germany, an evaluation of this new regulation is given. Since 2001, more than 1100 infection control visits in medical practices in Frankfurt am Main were documented. Not only in surgical, but also in gastroenterological and urological practices great improvement could be achieved, regarding not only hand hygiene and reprocessing surface areas, but especially in reprocessing medical devices. In practices for internal medicine and those of general practitioners, errors in hand hygiene, skin antiseptic and surface disinfection also decreased.

 

Major Infectious Disease Societies around the Globe

 

European Society of Clinical Microbiology and Infectious Diseases

International Union of Microbiological Societies

Federation of Infection Societies

Canadian Society of Microbiologists

British Infection Association

Federation of European Microbiological Societies

Welsh Microbiology Association

Clinical Virology Network

American Society for Microbiology

Society for General Microbiology

Infectious Diseases Society of America

 

Worldwide deaths due to Infectious Diseases

 

 

                               

Members associated with Infectious Diseases

  1. Centre for Infectious Diseases and Policy includes 218 members
  2. Global Public Health is having 106913 members
  3. Members Pediatric Infectious Disease and Immunology has 3291 members
  4. European Society of Clinical Microbiology and Infectious Diseases has 3438 members
  5. Infectious Diseases Society has 707 members

Universities related to Infectious Diseases

  1. University of Cambridge
  2. Kings College of London
  3. London School of Hygiene and Tropical Medicine
  4. Imperial College London
  5. UCL Institute of Epidemiology and Health care
  6. University of Sheffeild
  7. Pediatric Infectious Diseases Society
  8. Columbia University
  9. University of Maryland
  10. Swedish Institute for Infectious Disease Control
  11. Uppsala University
  12. University of Gothenburg
  13. University of Otago
  14. Oslo University
  15. University of Pittsburgh
  16. Emory Health Sciences
  17. Queensland University of Technology
  18. University of Liverpool
  19. University of Colorado Denver
  20. Infectious Diseases Society of America
  21.  Medical College of Georgia at Georgia Regents   University

Market Research on Infectious Diseases

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Market Analysis of Companies

 

Funding allotted for Infectious Diseases

The Centers for Disease Control and Prevention’s (CDC) Procurement and Grants Office (PGO) awards over 25,000 acquisition and assistance actions each year and obligates approximately $11 billion in federal funds. PGO aids in achieving CDC’s mission by quickly and effectively allocating funds to where they are needed. In its Pledge to the American People, CDC commits to being a diligent steward of the funds entrusted to the Agency. PGO ensures this pledge remains intact. To learn more about PGO, please review our FY 2014 Annual Report , Acquisition Snapshot , and Assistance Snapshot.

 

Global Prevalence of Infectious Diseases

The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012.  Market growth looks promising, the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%. The demographic transition is associated with an epidemiological transition in the causes and age of death. A predominant feature of this transition is a decrease in the number of deadly infections occurring during childhood. On the contrary, it is projected that, in 2020, three-quarters of all deaths in developing countries could be due to age-associated diseases. These are predominantly noncommunicable diseases, such ascardiovascular disease, cancer, and diabetes. What is the role of infection in the death of elderly individuals? Statistics from the WHO suggest that, in Europe and the United States, ∼5% of the population >60 years old will die as a consequence of infection, compared with ∼20% in Africa. However, although this relative difference in the importance of infection as a cause of death in industrialized countries versus developing countries is certainly relevant, the absolute numbers should be regarded with caution. Indeed, although studies using death certificates to identify causes of death usually find a relatively low importance of infection in industrialized countries, autopsy studies suggest a much higher contribution of infections to the overall causes of death (20%–30%). In the developing world, the leading infectious causes of death are respiratory tract infections, diarrheal diseases, tuberculosis, malaria, and AIDS, which together represent >90% of deaths. The remaining 10% are due to tropical diseases and various other infections. In industrialized countries, respiratory tract infections, bloodstream infections, urinary tract infections, and infections of the digestive system represent 90% of infection-related deaths; other diseases such as tuberculosis, hepatitis B and C, diarrheal diseases, and AIDS represent nearly all of the remaining 10%. As already stated by Kalache in 1996, many infectious diseases “no longer kill but neither do they die”. This aphorism is also a reminder that the impact of infectious diseases should not only be measured by mortality rate, but also by morbidity and quality of life, particularly in the aging population. These parameters are much more difficult to assess objectively, but understanding them will be increasingly important in the future.

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 5-6, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View